Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeoGenomics

6.72
-0.1900-2.75%
Post-market: 6.750.0300+0.45%19:58 EDT
Volume:1.41M
Turnover:9.65M
Market Cap:864.83M
PE:-11.00
High:7.06
Open:6.92
Low:6.69
Close:6.91
Loading ...

Neogenomics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Feb

Craig-Hallum Remains a Buy on NeoGenomics (NEO)

TIPRANKS
·
18 Feb

NeoGenomics (NEO) Tops Q4 Earnings Estimates

Zacks
·
18 Feb

Neogenomics Shares Fall 4.5% Premarket After Q4 Results

THOMSON REUTERS
·
18 Feb

NeoGenomics Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Drop Pre-Bell

MT Newswires Live
·
18 Feb

Stock Track | NeoGenomics Plunges 7.7% Pre-Market as Weak Q4 Results Disappoint

Stock Track
·
18 Feb

NeoGenomics: Q4 Earnings Snapshot

Associated Press Finance
·
18 Feb

BRIEF-Neogenomics Inc Reaffirms Full-Year 2025 Guidance

Reuters
·
18 Feb

GUIDANCE: (NEO) NeoGenomics Expects Full Year 2025 Consolidated Revenue Range $735M - $745M, vs. FactSet Est of $733.1M

MT Newswires Live
·
18 Feb

Earnings Flash (NEO) NeoGenomics Posts Q4 Revenue $172M, vs. FactSet Est of $173.2M

MT Newswires Live
·
18 Feb

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

StockStory
·
18 Feb

NeoGenomics reports Q4 adjusted EPS 4c, consensus 3c

TIPRANKS
·
18 Feb

NeoGenomics backs FY25 revenue view $735M-$745M, consensus $735.01M

TIPRANKS
·
18 Feb

Stock Track | NeoGenomics Soars 5% Pre-Market as Q4 Earnings Beat Estimates Despite Revenue Miss

Stock Track
·
18 Feb

NeoGenomics Q4 2024 Adj EPS $0.04 Beats $0.03 Estimate, Sales $172.00M Miss $173.18M Estimate

Benzinga
·
18 Feb

Neogenomics Inc - Reaffirms Full-Year 2025 Guidance

THOMSON REUTERS
·
18 Feb

Neogenomics Inc Qtrly Loss per Share $0.12

THOMSON REUTERS
·
18 Feb

Neogenomics Inc FY2025 Shr View $0.20, REV View $733.0 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
18 Feb

Neogenomics Q4 Revenue USD 172 Million VS. Ibes Estimate USD 173.2 Million

THOMSON REUTERS
·
18 Feb

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

Business Wire
·
18 Feb